Medtronic Q1 FY27 revenue up 13.7% to $9.76B; raises FY27 guidance

Medtronic plc

Q1 revenue $9.756B, +13.7% reported and organic; GAAP EPS $1.14, non-GAAP EPS $1.45.
Raises FY27 organic revenue growth to 7.25-7.75% (from 6.75-7.25%) and non-GAAP EPS to $5.94-6.00.
Cardiovascular +18.9% organic, Neuroscience +9.3%, Medical Surgical +10.2%, Diabetes +14.9%.
Extra fiscal week added ~$570M to Q1 organic growth; completed acquisitions of Scientia Vascular and SPR Therapeutics.
Announced strategic investments in Pi-Cardia and Cornerstone Robotics; FDA clearance for Touch Surgery Aide.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.